ACTISOUFRE, solution pour pulvérisation nasale/buccale en flacon pressurisé, Actisoufre Placebo
ARG-01-2024
Phase 3 small_molecule active
Quick answer
ACTISOUFRE, solution pour pulvérisation nasale/buccale en flacon pressurisé, Actisoufre Placebo for rhinosinusitis not requiring antibiotic therapy, rhinopharyngitis not requiring antibiotic therapy, Acute rhinitis not requiring antibiotic therapy is a Phase 3 program (small_molecule) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratoire HRA Pharma
- Indication
- rhinosinusitis not requiring antibiotic therapy, rhinopharyngitis not requiring antibiotic therapy, Acute rhinitis not requiring antibiotic therapy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active